Lessons from 20 years of medical cannabis use in Canada. by Minsup Shim, Hai Nguyen, Paul Grootendorst

“…However, literature on Canada's medical cannabis program is limited.<h4>Methods</h4>We use administrative data from the medical cannabis program, and licensed cannabis vendor catalog data to describe a) the participation of patients, physicians, and cannabis vendors in the program from its inception in 1999 to 2021, and b) trends in medical cannabis consumption, prices and potency. …”
Get full text

Medical Cannabis for the Treatment of Migraine in Adults: A Review of the Evidence by Babasola O. Okusanya, Breanne E. Lott, John Ehiri, Jean McClelland, Cecilia Rosales

Subjects: Get full text

Fungal Pathogens Affecting the Production and Quality of Medical Cannabis in Israel by Shachar Jerushalmi, Marcel Maymon, Aviv Dombrovsky, Stanley Freeman

Subjects: Get full text

Use of non-medical cannabis in epilepsy: A scoping review by Jimmy Li, Jimmy Li, Cassandra C. Areal, Dènahin Hinnoutondji Toffa, Dènahin Hinnoutondji Toffa, Daphné Citherlet, Charles Deacon, Didier Jutras-Aswad, Didier Jutras-Aswad, Mark Robert Keezer, Mark Robert Keezer, Mark Robert Keezer, Mark Robert Keezer, Dang Khoa Nguyen, Dang Khoa Nguyen, Dang Khoa Nguyen

“…ObjectiveThe use of medical cannabis among people with epilepsy (PWE) has been garnering increasing interest. …”
Get full text

The model of care at a leading medical cannabis clinic in Canada by Erin Prosk, Maria Fernanda Arboleda, Lucile Rapin, Cynthia El Hage, Michael Dworkind

Subjects: “…Medical cannabis…”
Get full text

Medical cannabis in chronic pain management – Where are we now? by Shamim Haider, Wan Jane Liew

Subjects: Get full text

Lessons from 20 years of medical cannabis use in Canada by Minsup Shim, Hai Nguyen, Paul Grootendorst

“…However, literature on Canada’s medical cannabis program is limited. <h4>Methods</h4> We use administrative data from the medical cannabis program, and licensed cannabis vendor catalog data to describe a) the participation of patients, physicians, and cannabis vendors in the program from its inception in 1999 to 2021, and b) trends in medical cannabis consumption, prices and potency. …”
Get full text

Case report: Medical cannabis—warfarin drug-drug interaction by Tyan F. Thomas, Evdokia S. Metaxas, Thu Nguyen, Whitni Bennett, Kathryn V. Skiendzielewski, Diane H. Quinn, Alice L. Scaletta

Subjects: Get full text

Medical cannabis use in older patients : update on medical knowledge by Beauchet, Olivier

“…A mini-review was conducted to examine the evidence on medical cannabis use in older patients.…”
Get full text

The impact of non-medical cannabis legalization and other exposures on retention in longitudinal cannabis research: a survival analysis of a prospective study of Canadian medical cannabis patients by Philippe Lucas, Susan Boyd, M.-J. Milloy, Zach Walsh

“…Additionally, policy-related changes aimed at improving access to medical cannabis, including increased cost-coverage and community-based distribution, could encourage patients to remain in the federal medical cannabis program and thereby reduce LTFU in associated studies.…”
Get full text

Estimated Cost of Production for Medical Cannabis (Cannabis sativa L.) in Greece by Chariklia CHATZIGIANNI, Ioannis ROUSSIS, Christos T. PAPADAS, Stella KARIDOGIANNI, Varvara KOUNELI, Ioanna KAKABOUKI, Antigolena FOLINA, Panayiota PAPASTYLIANOU, Dimitrios BILALIS

Subjects: Get full text

Medical Cannabis Activity Against Inflammation: Active Compounds and Modes of Action by Seegehalli M. Anil, Hadar Peeri, Hinanit Koltai

Get full text

Medical cannabis use in the United States: a retrospective database study by V. Kishan Mahabir, Jamil J. Merchant, Christopher Smith, Alisha Garibaldi

Subjects: “…Medical cannabis…”
Get full text

Benefits and harms of medical cannabis: a scoping review of systematic reviews by Misty Pratt, Adrienne Stevens, Micere Thuku, Claire Butler, Becky Skidmore, L. Susan Wieland, Mark Clemons, Salmaan Kanji, Brian Hutton

Get full text

Exploring medical cannabis use in individuals with a traumatic brain injury by Elizabeth N. R. Schjelderup, Caroline A. MacCallum, Lindsay A. Lo, Jessie Dhillon, April Christiansen, Carly Pistawka, Kathryn Rintoul, William J. Panenka, Alasdair M. Barr

“…In part because of this, there is growing interest in the use of medical cannabis to treat the sequelae of TBI, as medical cannabis has been used to treat multiple associated conditions, such as pain. …”
Get full text

Perspectives on formation of medical cannabis market in Ukraine based on holistic approach by Nataliia Aliekperova, Кostyantyn Kosyachenko, Oleksandr Kaniura

Subjects: “…Medical cannabis…”
Get full text

Attitudes of Israeli Rheumatologists to the Use of Medical Cannabis as Therapy for Rheumatic Disorders by Jacob N. Ablin, Ori Elkayam, Mary-Ann Fitzcharles

Subjects: “…Medical cannabis…”
Get full text

Regulating compassion: an overview of Canada's federal medical cannabis policy and practice by Lucas Philippe G

“…Canada's community-based dispensaries supply medical cannabis to a far greater number of patients than the MMAD, but their work is currently unregulated by any level of government, leaving these organizations and their clients vulnerable to arrest and prosecution.…”
Get full text

Shifts in medical cannabis use in Canada during the COVID-19 pandemic by Stephanie Lake, Ziva D. Cooper, Kaye Ong, Philippe Lucas

“…While increases in the nonmedical use of certain substances, including cannabis, have been observed in samples of the Canadian population, no research has documented COVID-concurrent shifts in medical cannabis use in Canada. MethodsData were derived from the 2021 Canadian Cannabis Patient Survey, an online survey administered in May 2021 to people authorized to use medical cannabis recruited from one of two Canadian licensed medical cannabis producers. …”
Get full text

Medical Cannabis: A Review from the American Society of Pain and Neuroscience by Strand N, D’Souza RS, Karri J, Kalia H, Weisbein J, Kassa BJ, Hussain N, Chitneni A, Budwany RR, Hagedorn J, Pope JE, Deer TR, Sayed D, Abd-Elsayed A

“…However, both safety and efficacy data for medical cannabis treatment of chronic, nonmalignant pain conditions are lacking. …”
Get full text